The Chase Family Movement Disorders Center offers opportunities for active participation in cutting edge research in the field through clinical trials.

These studies are conducted in collaboration with other movement disorders specialists throughout North America and Europe. We have several ongoing clinical research studies as noted below, and all patients have the option to participate in one or more clinical trials.

We are also involved in mentoring students and physicians-in-training who will serve the community in the future as neurologists, researchers, or in primary care. 

Clinical Trials

The Chase Family Movement Disorders Center continues to seek new ways to slow the progression of neurodegenerative disorders through clinical trials in collaboration with other movement disorders spe

  1. Protocol No: P2B001/003 (enrolling) A Phase 3, 12 week, multi-center, multinational, Randomized, Double Blind, Double Dummy, Parallel Group Study to determine the Efficacy, Safety, and Tolerability of P2B001 Once Daily Compared to its Individual Components in Subjects with Early Parkinson’s Disease and to a Calibration Arm of Pramipexole ER.

  2. Protocol No: Eli Lilly 17S-MC-HBEH (enrolling) A Phase 2 12-week study on the Effect of LY3154207 on Cognition in Mild-to-Moderate Parkinson’s Disease Dementia (PDD).

  3. Protocol HHC-2020-0021 - Malnutrition and Weight Loss in Parkinson’s Disease

Chase Family Movement Disorders Center

  • Contact Us

    Phone: 860.870.6385
    Fax: 860.870.0625

  • Clínica Hispana del Centro de Trastornos del Movimiento Chase Famil

    Teléfono: 860.870.6385 
    Fax: 860.545.1201

  • Help our patients continue to do the things that they need to do and like to do.

    We're passionate about enhancing our patients’ lives, so we are developing a patient-driven program to meet the needs expressed by patients themselves. Can you help?

    Donate Now >>